SunQuantum, Inc.

SunQuantum is a quantum hardware startup developing proprietary superconducting materials and devices for quantum computing. Building on Cornell-licensed technology, SunQuantum is developing superconducting qubit wafers designed to enable longer coherence and more scalable quantum computers.

MedSimAI, Inc.

MedSimAI is an AI-powered simulation and assessment platform for health professions education that lets learners practice clinical encounters with AI-simulated patients and receive personalized feedback from AI preceptors on their clinical skills and reasoning.

ChitterChatter

ChitterChatter turns an instructor’s own course materials into AI conversation partners, giving language students unlimited speaking practice outside of class. Students get instant feedback on every attempt, and instructors get a class-level view of who is practicing and where the difficulty is.

Contour Medical

Contour Medical is a novel solution to treat cardiac arrhythmia with a mission to revolutionize and democratize cardiac ablation.

Lucentia, Inc.

Lucentia, Inc. is developing AI-powered software that transforms standard, non-contrast CT scans into high-fidelity coronary images, delivering contrast-quality cardiac diagnostics without the cost, risk, or complexity of contrast agents.

IVSonance Biomedical Inc.

IVSonance Biomedical Inc. is developing SOUND™ (Selective Ova Ultrasound Non-Contact Denudation), a contactless acoustic micromanipulation platform designed to automate oocyte denudation, one of the most technically demanding manual steps in IVF.

Forage Evolution

Forage Evolution is developing a next-generation bacterial transformation platform that replaces E. coli as the workhorse of molecular cloning. The Forager-Fast Plasmid Subcloning Kit combines a patented host organism with proprietary formulations engineered through applied physics and biochemistry to dramatically accelerate DNA transfer into bacterial cells — enabling plasmid assembly to colonies in under 7 hours.

Persista Bio

Persista Bio is developing the O2Line™ System, a pre-clinical, oxygenated implantable cell therapy platform co-developed with Giner, Inc. that overcomes the two core barriers limiting current cell therapies: immune rejection and oxygen deprivation.

Chiara Biosciences

Chiara Biosciences is creating a new category of targeted protein degraders with its proprietary CURE-PRO™ platform, which uses a “puzzle-piece” approach to overcome the size and geometry limitations of first-generation degraders. The platform enables oral delivery, CNS penetration, and the rapid discovery of novel degrader pairs. Chiara’s unique combinatorial strategy supports a high throughput, reusable platform for developing both an internal pipeline and collaborative solutions for strategic CURE-PRO development.

SensVita, Inc.

SensVita is advancing at-home healthcare delivery with next-generation touchless sensors for continuous and passive cardiopulmonary monitoring. Its patented technology captures a wide range of vital cardiac and respiratory endpoints without any skin contact, enabling seamless integration into over-clothes wearables or furniture-embedded sensing pads. This approach addresses one of the most critical challenges in remote monitoring—low patient compliance.